Skip to main content

Root Canal Obturation

0
Pipeline Programs
1
Companies
3
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Septodont
SeptodontFrance - Saint-Maur-des-Fosses
3 programs
BioRootTM RCSN/A1 trial
Endomethasone N RCSN/A1 trial
ready-to-use root canal sealer: PA1704N/A1 trial
Active Trials
NCT05247138Recruiting142Est. Jul 2029
NCT04885686Completed300Est. Jun 2022
NCT04757753Active Not Recruiting160Est. Jul 2026

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
SeptodontBioRootTM RCS
SeptodontEndomethasone N RCS
Septodontready-to-use root canal sealer: PA1704

Clinical Trials (3)

Total enrollment: 602 patients across 3 trials

Measurement of the Clinical and Radiological Performance Impact of the Root Canal Treatment With BioRootTM RCS.

Start: Feb 2022Est. completion: Jul 2029142 patients
N/ARecruiting
NCT04885686SeptodontEndomethasone N RCS

Endodontic Post-operative Pain Evaluation of Patients After Using Endomethasone N or Endomethasone SP (EndoPOP)

Start: Jun 2021Est. completion: Jun 2022300 patients
N/ACompleted
NCT04757753Septodontready-to-use root canal sealer: PA1704

Root Canal Obturation With a Ready-to-use Root Canal Sealer (PA1704) Versus BioRoot™ RCS: a Randomized Controlled Trial

Start: Nov 2020Est. completion: Jul 2026160 patients
N/AActive Not Recruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 602 patients
1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.